Blinatumomab Interactions
There are 285 drugs known to interact with blinatumomab, along with 8 disease interactions. Of the total drug interactions, 63 are major, 199 are moderate, and 23 are minor.
- View all 285 medications that may interact with blinatumomab
- View blinatumomab disease interactions (8)
Most frequently checked interactions
View interaction reports for blinatumomab and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Activated Charcoal (charcoal)
- Adalat CC (nifedipine)
- Adderall XR (amphetamine / dextroamphetamine)
- Adeks (multivitamin with minerals)
- Ambien (zolpidem)
- Ambien CR (zolpidem)
- Bactrim (sulfamethoxazole / trimethoprim)
- Calcium Oyster Shell (calcium carbonate)
- Claravis (isotretinoin)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Crestor (rosuvastatin)
- Daytrana (methylphenidate)
- Desferal (deferoxamine)
- Dextrose (glucose)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lithium Carbonate ER (lithium)
- Paracetamol (acetaminophen)
- Rutin (bioflavonoids)
- Valproate Sodium (valproic acid)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
Blinatumomab disease interactions
There are 8 disease interactions with blinatumomab which include:
- vaccination
- leukoencephalopathy
- liver dysfunction
- metabolic acidosis
- neurologic disorders
- neutropenia
- pancreatitis
- renal impairment
Report options
QR code containing a link to this page
More about blinatumomab
- blinatumomab consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
